Abatacept in Treatment Resistant Nephrotic Syndrome
BWH is now enrolling patients with Nephrotic Syndrome in this clinical trial. Call the Kidney-NExT Clinic at 617-732-6383 to enroll.
Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children Over the Age of 6 With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD) - Read More
Center for Kidney Disease and Novel Experimental Therapeutics (Kidney-NExT)